Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- cefaleia episódica intenso
- náuseas e vômitos
- sensibilidade à luz e a ruídos
- impacto funcional
- sintomas de aura
- sensação latejante
Fatores de risco
- história familiar de enxaqueca
- sexo feminino e alterações hormonais
- má qualidade do sono
- estresse
- uso excessivo de medicamentos
- síndromes periódicas
Investigações diagnósticas
Investigações a serem consideradas
- ressonância nuclear magnética (RNM) cranioencefálica
- eletroencefalograma
- punção lombar
- velocidade de hemossedimentação (VHS) e proteína C-reativa
- tomografia computadorizada (TC) de crânio
Algoritmo de tratamento
Colaboradores
Autores
Cristian Ionita, MD
Associate Professor of Clinical Pediatrics (Neurology)
Yale School of Medicine
New Haven
CT
Declarações
CI declares that he has no competing interests.
Agradecimentos
Dr Christian Ionita would like to gratefully acknowledge Dr Nick Barnes, a previous contributor to this topic.
Declarações
NB declares that he has no competing interests.
Revisores
Kenneth Mack, MD, PhD
Medical Director
Mayo Clinic Pediatric Center
Rochester
MN
Declarações
KM declares that he has no competing interests.
Tony McShane, MBBS
Consultant Paediatric Neurologist
John Radcliffe Hospital
Oxford
UK
Declarações
TM declares that he has no competing interests.
Sandeep Jayawant, MBBS
Consultant Paediatric Neurologist
John Radcliffe Hospital
Oxford
UK
Declarações
SJ declares that he has no competing interests.
Howard S. Jacobs, MD
Associate Professor
Co-Director Pediatric Headache Clinic
University of Maryland School of Medicine
Baltimore
MD
Declarações
HSJ declares that he has no competing interests.
Referências
Principais artigos
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.Texto completo Resumo
Oskoui M, Pringsheim T, Billinghurst L, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10;93(11):500-9.Texto completo Resumo
Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: acute treatment of migraine in children and adolescents. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10;93(11):487-99.Texto completo Resumo
Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016 Apr 19;(4):CD005220.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível aqui.
O uso deste conteúdo está sujeito ao nosso aviso legal